Death Cross Looms Over PerkinElmer Investors
Today, 9:43 PM
If history is any guide, there may be trouble ahead for shares of PerkinElmer (NYSE:PKI). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Earnings Scheduled For March 3, 2022
Today, 9:43 PM
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
Recap: PerkinElmer Q4 Earnings
Today, 9:43 PM
PerkinElmer (NYSE:PKI) reported its Q4 earnings results on Tuesday, February 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
PerkinElmer Q4 Adj. EPS $2.56 Beats $2.20 Estimate, Sales $1.36B Beat $1.29B Estimate
Today, 9:43 PM
PerkinElmer (NYSE:PKI) reported quarterly earnings of $2.56 per share which beat the analyst consensus estimate of $2.20 by 16.36 percent. This is a 35.35 percent decrease over earnings of $3.96 per share from the same
10 Health Care Stocks Whale Activity In Today’s Session
Today, 9:43 PM
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
PerkinElmer Sees Q4 Adj. EPS $2.40+ vs $2.12 Est., Sees COVID-Related Revenues ~$320M
Today, 9:43 PM
Fourth quarter 2021 revenue and earnings per share to exceed prior guidance
Non-COVID organic growth in fourth quarter 2021 of approximately 10%
Fourth quarter 2021 COVID product and
10 Health Care Stocks Whale Activity In Today’s Session
Today, 9:43 PM
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Carterra, PerkinElmer Sign Distribution Agreement For Asia-Pacific And Oceania Region For Carterra’s High Throughput Antibody Screening And Characterization Solutions
Today, 9:43 PM
Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has signed an exclusive Asia-Pacific and Oceania region distribution agreement with